Outside experts are reportedly advising the White House to scrap its universal COVID-19 booster plan


Several outside experts had an off-the-record phone call with federal health officials last week during which they objected to the White House's plan to eventually make COVID-19 vaccine booster shots available to all previously-vaccinated adults, Politico reports, citing five people familiar with the matter. The experts reportedly made the case that current data does not back up the strategy and that only people who are at most at risk of severe coronavirus infections should get the extra dose.
The phone call was "very tense," one source told Politico, and involved pretty clear disagreements between the outside voices and Dr. Anthony Fauci, President Biden's chief medical adviser. Fauci is in the camp that supports a wide booster rollout with the goal of reducing the spread of the virus, rather than just limiting hospitalizations and death. He also argued the U.S. didn't face a choice between boosters and donating extra doses to other countries that need their initial shots. Several participants on the call were left "mystified" by the exchange and the government's plan, Politico reports. Read more about Politico.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
The battle over Jamaican rum
Under The Radar The spirit that defines the Caribbean is at the middle of a legal fight
By Rebekah Evans, The Week UK Published
-
Do student loans affect a credit score?
the explainer Repaying loans on time will strengthen your credit — but paying late will hurt it
By Becca Stanek, The Week US Published
-
Cherry blossom season: Washington diners’ happy time
feature The five best spots to enjoy the festivities
By The Week US Published
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
By Peter Weber, The Week US Published
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
By Peter Weber, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published